Moreover, inhibition of ERK signaling using a MAPK kinase inhibitor was demonstrated to exert a synergistic effect with RG7388 on tumor growth in DDLPS [37] providing a rationale to investigate the potential of dual targeting of FGFR and MDM2 in WDLPS and DDLPS cells. Here, MDM2 is linked to neoplasm.